BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19120859)

  • 1. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan.
    Kusano C; Gotoda T; Khor CJ; Katai H; Kato H; Taniguchi H; Shimoda T
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1662-5. PubMed ID: 19120859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma of the esophagogastric junction: do we see more or less?
    Yee YK; Wong BC
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1627-8. PubMed ID: 19120853
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
    Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
    J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma.
    Takeda FR; Ramos MFKP; Pereira MA; Sallum RAA; Ribeiro Junior U; Nahas SC; Cecconello I
    Updates Surg; 2022 Dec; 74(6):1871-1879. PubMed ID: 35776245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
    Fu J; Tang L; Li Z; Li X; Zhang Y; Gao S; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1013-1018. PubMed ID: 30269321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
    Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
    World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival rate of proximal and total gastrectomy in treatment of esophagogastric junction adenocarcinoma (Siewert II( Types)].
    Nai C; Liu Z; Lian X; Liu S; Guo M; Xiao S; Liu J; Yang X; Zhang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):195-9. PubMed ID: 26831885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients.
    Imamura Y; Watanabe M; Toihata T; Takamatsu M; Kawachi H; Haraguchi I; Ogata Y; Yoshida N; Saeki H; Oki E; Taguchi K; Yamamoto M; Morita M; Mine S; Hiki N; Baba H; Sano T
    Digestion; 2019; 99(1):6-13. PubMed ID: 30554205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends.
    Kumamoto T; Kurahashi Y; Niwa H; Nakanishi Y; Okumura K; Ozawa R; Ishida Y; Shinohara H
    Surg Today; 2020 Aug; 50(8):809-814. PubMed ID: 31278583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
    Oh SE; Lee GH; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
    Eur J Surg Oncol; 2022 Feb; 48(2):370-376. PubMed ID: 34433514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endoscopic therapy for cancer of the esophagogastric junction].
    Fujisaki J; Omae M; Shimizu T; Morishige K; Miyamoto Y; Taniguchi C; Horiuchi Y; Yoshio T; Ishiyama A; Hirasawa T; Yamamoto Y; Tsuchida T; Igarashi M
    Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):29-34. PubMed ID: 25842810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.
    Suh YS; Han DS; Kong SH; Lee HJ; Kim YT; Kim WH; Lee KU; Yang HK
    Ann Surg; 2012 May; 255(5):908-15. PubMed ID: 22504190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment approaches to esophagogastric junction tumors.
    Kurokawa Y; Sasako M; Doki Y
    Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma.
    Gong EJ; Kim DH; Ahn JY; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim HS; Lee IS; Kim BS; Yoo MW; Oh ST; Yook JH; Kim BS
    Gastric Cancer; 2017 Mar; 20(Suppl 1):84-91. PubMed ID: 27995482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
    Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
    Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma.
    Uedo N; Yoshio T; Yoshinaga S; Takeuchi M; Hatta W; Yano T; Tanuma T; Goto O; Takahashi A; Tong D; Lee YY; Nakayama Y; Ichihara S; Gotoda T
    Dig Endosc; 2017 Apr; 29 Suppl 2():26-36. PubMed ID: 28425653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin phenotypic expression and background mucosa of esophagogastric junctional adenocarcinoma.
    Tsuji N; Ishiguro S; Tsukamoto Y; Mano M; Kasugai T; Miyashiro I; Doki Y; Iishi H; Kudo M
    Gastric Cancer; 2004; 7(2):97-103. PubMed ID: 15224196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
    Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
    Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.